Indivior Pharmaceuticals (INDV) Assets Average (2024 - 2026)

Indivior Pharmaceuticals' Assets Average history runs 3 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Assets Average fell 10.89% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (down 10.89% YoY), while the FY2025 annual figure was $1.3 billion, down 18.12% from the prior year.
• Assets Average was $1.2 billion for Q1 2026 at Indivior Pharmaceuticals, down from $1.3 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.7 billion in Q3 2024 to a low of $1.2 billion in Q1 2026.
• Historically, Assets Average has averaged $1.6 billion across 3 years, with a median of $1.4 billion in 2025.
• The sharpest annual moves came in 2025 and 2026: Assets Average slumped 46.59% in 2025, then dropped 10.89% in 2026.
• A 3-year view of Assets Average shows it stood at $1.5 billion in 2024, then fell by 15.17% to $1.3 billion in 2025, then slipped by 8.37% to $1.2 billion in 2026.
• The last three Assets Average figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.